1. Takashi,Hashimoto 日本 Yokohama City Minato Red Cross Hospital Potential contribution of anti-p200 autoantibodies to mucosal lesions in anti-p200 pemphigoid
2. Huizinga, Thomas W. J. 荷兰 Leiden University Comprehensive overview of autoantibody isotype and subclass distribution
3. Theo,Rispens 荷兰 University of AMSTERDAM Comprehensive overview of autoantibody isotype and subclass distribution
4. Maarten J,Titulaer 荷兰 Erasmus University Comprehensive overview of autoantibody isotype and subclass distribution
5. René E. M,Toes 荷兰 Leiden University Comprehensive overview of autoantibody isotype and subclass distribution
6. Tsai, Tsen-Fang 中国 国立台湾大学 Management of Coexisting Bullous Pemphigoid and Psoriasis: A Review
7. Cohen, Arnon D. 以色列 Ben Gurion University Treatment and clinical outcomes in anti-p200 pemphigoid: a systematic review
8. Ahmed, A. Razzaque 美国 Tufts University School of Medicine Anti-p200 Pemphigoid: A Systematic Review
9. Detlef,Zillikens 德国 University of Lubeck Anti-p200 pemphigoid
10. Steven M,Horwitz 美国 Memorial Sloan-Kettering Cancer Center Cutaneous T-cell lymphoma (CTCL), rare subtypes: five case presentations and review of the literatur..
11. Kenji,Kabashima 日本 Kyoto University Interaction of Psoriasis and Bullous Diseases
12. Victor G,Prieto 美国 University of Texas MD Anderson Cancer Center Cutaneous angiosarcoma: a current update
13. David T,Teachey 美国 University of Pennsylvania Severe Mucha-Habermann-Like Ulceronecrotic Skin Disease in T-Cell Acute Lymphoblastic Leukemia Respo..
14. Schmidt, Enno 德国 University of Lubeck A refractory, cutaneous, subepidermal bullous disease
15. Takashi,Hashimoto 日本 Yokohama City Minato Red Cross Hospital A refractory, cutaneous, subepidermal bullous disease
16. Detlef,Zillikens 德国 University of Lubeck A refractory, cutaneous, subepidermal bullous disease
17. Eli,Sprecher 以色列 Tel Aviv Sourasky Medical Center A refractory, cutaneous, subepidermal bullous disease
18. Takashi,Hashimoto 日本 Yokohama City Minato Red Cross Hospital What are the "True" Pathogenic Anti-desmoglein Antibodies? Response